The Ministry of Health has launched BIFIMED, a new interactive tool that provides detailed information about whether a drug previously authorised by the National Health System is financed by the public system, and for what indications. This tool is accessible to any interested public, including insurees, and it is updated on a monthly basis.
A quick glance at the existing information within BIFIMED reveals that, for example, 4,975 authorised drugs (out of 32,179) were not publicly financed, corresponding 62% (out of 17029 applications) to generic drugs, 6% (out of 1632 applications) to biological drugs and 1% to orphan drugs (out of 193 applications).
Furthermore, the number of funding refusals has increased steadily since 2005. For example, up to now in 2019 there has been 675 negative resolutions, a 33% of the funding applications this year, compared to the 121 refusals (16% of the total) issued in 2005.
More information (in Spanish):